Watch the slideshow for a better understanding: https://youtu.be/frmGwCEtDnM
1. Learn how mRNA vaccines work.
2. Learn challenges in making HIV vaccines.
3. Learn about the advantage of mRNA vaccines in HIV
4. Learn about trials.
The development of an HIV vaccine faces significant challenges including viral diversity, establishment of viral reservoirs, and immune evasion. Current vaccine strategies aim to elicit broadly neutralizing antibodies or enhance cellular immunity through various approaches including recombinant proteins, viral vectors, and DNA vaccines. While two vaccine concepts have undergone efficacy trials, neither provided protective effects. Ongoing research continues through clinical trials evaluating prime-boost regimens combining DNA vaccines and viral vectors.
MVI is working with ICGEB in India to develop a vaccine against Plasmodium vivax. This effort includes Bharat Biotech, which will manufacture the vaccine for preclinical and initial safety trials in adults. The vaccine aims to prevent infection, decrease infection intensity, and prevent malaria transmission.
A brief overview of the process of vaccine production, clinical trials, and licensing, along with a summary of the different vaccines platforms and vaccine candidates.
This slide tries to explain and introduce you to the mRNA Vaccine Technology, describes mRNA Vaccines, Mechanism , Delivery, some research and case study of pandemic and advantages disadvantages & application see for yourself in detail.
The document summarizes information about COVID-19 mRNA vaccines, including their development, clinical trials, efficacy, safety considerations, and side effects. Some key points:
- The Pfizer/BioNTech and Moderna COVID-19 vaccines were the first mRNA vaccines approved for emergency use. Clinical trials found them to be over 94% effective with common side effects being pain, swelling at the injection site, fever, and fatigue.
- mRNA vaccines work by providing genetic instructions for cells to make the spike protein found on the COVID-19 virus, training the immune system without exposing the body to the live virus.
- Reported safety data found most side effects to be mild-to-moderate and resolve
In this presentation, I talked about the new mRNA vaccine that is authorized for the prevention of coronavirus infection.
mRNA 1273 is developed by Moderna in the US and has shown almost 94% effectiveness
The development of an HIV vaccine faces significant challenges including viral diversity, establishment of viral reservoirs, and immune evasion. Current vaccine strategies aim to elicit broadly neutralizing antibodies or enhance cellular immunity through various approaches including recombinant proteins, viral vectors, and DNA vaccines. While two vaccine concepts have undergone efficacy trials, neither provided protective effects. Ongoing research continues through clinical trials evaluating prime-boost regimens combining DNA vaccines and viral vectors.
MVI is working with ICGEB in India to develop a vaccine against Plasmodium vivax. This effort includes Bharat Biotech, which will manufacture the vaccine for preclinical and initial safety trials in adults. The vaccine aims to prevent infection, decrease infection intensity, and prevent malaria transmission.
A brief overview of the process of vaccine production, clinical trials, and licensing, along with a summary of the different vaccines platforms and vaccine candidates.
This slide tries to explain and introduce you to the mRNA Vaccine Technology, describes mRNA Vaccines, Mechanism , Delivery, some research and case study of pandemic and advantages disadvantages & application see for yourself in detail.
The document summarizes information about COVID-19 mRNA vaccines, including their development, clinical trials, efficacy, safety considerations, and side effects. Some key points:
- The Pfizer/BioNTech and Moderna COVID-19 vaccines were the first mRNA vaccines approved for emergency use. Clinical trials found them to be over 94% effective with common side effects being pain, swelling at the injection site, fever, and fatigue.
- mRNA vaccines work by providing genetic instructions for cells to make the spike protein found on the COVID-19 virus, training the immune system without exposing the body to the live virus.
- Reported safety data found most side effects to be mild-to-moderate and resolve
In this presentation, I talked about the new mRNA vaccine that is authorized for the prevention of coronavirus infection.
mRNA 1273 is developed by Moderna in the US and has shown almost 94% effectiveness
Overview of vaccine and vaccination, types of vaccines with examples, vaccine production technique, adverse effects of vaccination, precautions
Email: jeevan@smail.nchu.edu.tw
This document provides an overview of DNA vaccines. It begins with introducing traditional vaccines and how DNA vaccines work. DNA vaccines use genetically engineered DNA that is injected into cells to produce an immunological response. The document then covers the history, development, delivery methods, mechanisms of action, advantages, disadvantages, and current/future applications of DNA vaccines. It summarizes that DNA vaccination is a promising new approach being tested for diseases like Alzheimer's, West Nile virus, and dental caries.
Over 60 million people have been infected with HIV since 1981, and 39.5 million people are currently living with HIV. There are still around 4.3 million new infections each year, and over 28 million people have died of AIDS-related illnesses since the start of the pandemic. Developing an effective HIV vaccine has proven extremely challenging due to the virus's ability to mutate and evade the immune system. While several vaccine candidates have reached clinical trials, none have yet provided reliable, long-term sterilizing immunity. Continued research efforts aim to develop a vaccine that can eliminate HIV infections and end the pandemic.
mRNA rather than DNA may become the nucleotide framework for new classes of drugs and vaccines. Exciting preclinical results in prophylaxis and initial clinical data in oncology suggest that mRNA technology could be translated into improvements in lung cancer and other diseases.
Vaccines are valuable and specialized products, of great diversity have already achieved great success in controlling many diseases of economics importance in farm and companion animals, but present they do not cover all infections, access to modern techniques are used for designing to new vaccine ,not only prolongation of immunity, but also to better practical aspects, such as product stability and less dependence on cold-storage.
Vaccine discovery
DNA vaccine, mechanism
methods of delivery
Main concerns: do DNA vaccines cause insertional mutation and elicit anti-DNA antibodies in the body?
completed and ongoing trials.
new strategies: Prime Boost vaccines
Future prospects
This document provides information about COVID-19 vaccines, including their development process and types. It discusses the phases of clinical drug trials, with Phase 1 trials testing safety in a small group and Phase 3 trials comparing the new vaccine to the standard treatment in thousands of participants. The document also outlines regulatory bodies involved in vaccine development and describes two main types - mRNA vaccines, which introduce mRNA coding for the antigen, and viral vector vaccines, which use another virus to produce the spike protein antigen.
This document summarizes different strategies for developing an HIV vaccine, outlining the challenges and current state of different vaccine types. It discusses how vaccines could potentially prevent or treat HIV infection, and highlights the obstacles like HIV's ability to mutate and target immune cells. Different vaccine types currently in clinical trials are described, including peptides, DNA, live vectors, and recombinant proteins. The largest vaccine trial to date, AIDSVAX, is summarized as stimulating antibodies but not proving effective against HIV.
Therapeutic Cancer Vaccines: A Future of Possibilities Haunted By A History o...Michael Sheckler
These slides provide an overview of 100 therapeutic cancer vaccines in development, a look at some of the failures, what's been and is being done to address the clinical development of these vaccines and a snapshot of some deals, terms and the number of companies seeking commercializations partners.
This document summarizes the history and development of cancer vaccines from early experiments in mice to current human clinical trials. It discusses key concepts like antigen presentation and types of vaccine components. Murine studies showed synergistic effects of combining vaccines with checkpoint inhibitors. Human trials demonstrated the first FDA-approved therapeutic cancer vaccine Provenge for prostate cancer in 2010 and the oncolytic virus therapy T-VEC for melanoma in 2015. Data from the NCI Surgery Branch showed durable responses in some patients treated with personalized peptide vaccines.
mRNA vaccines are a novel vaccine technology that deliver mRNA encoding the antigen protein of a pathogen. This allows the antigen protein to be expressed by the recipient's cells and stimulate an immune response. There are two main types of mRNA vaccines - non-replicating mRNA and self-amplifying mRNA. Delivery strategies include viral carriers like lentivirus or non-viral carriers like liposomes. Administration routes include intramuscular injection, intradermal injection, and intranodal injection. Creative Biolabs offers several mRNA vaccine platforms including non-replicating mRNA vaccines, self-amplifying mRNA vaccines, and dendritic cell mRNA vaccines.
Developing vaccines against infectious and epidemic diseases with the aid of Bioinformatics is now possible, by predicting epitopes on an antigen and finding possible targets for the antibody to bind. A new era of vaccine production is just ahead of us.
Watch out the ppt to know more!!!
mRNA vaccine is a novel vaccine technology, which delivers mRNA that encoding the antigen protein of pathogen to the cell, and expresses the antigen protein, and then stimulates the immune response of the body.
Creative Biolabs has developed non-replicating mRNA vaccine platform, mRNA vaccine platform, mRNA pharmacology optimization platform, and and Self-amplifying mRNA vaccine platform to spport your vaccine researches. If you need more information about mRNA vaccine, please follow us.
This document presents information on vector vaccines. It defines vector vaccines as using live, attenuated microorganisms like viruses or bacteria that have been genetically modified to express antigens from pathogenic organisms. This allows the vector to act as an antigen delivery system, stimulating an immune response against the pathogen. Common viral vectors discussed are vaccinia virus and adenovirus, while bacterial vectors include attenuated Salmonella. The document outlines the process of producing a vaccinia vector vaccine and discusses advantages like strong immunogenicity and ability to induce different types of immune responses. However, it also notes disadvantages such as high production costs and safety concerns in immunocompromised individuals.
Retroviruses can be used as tools in cell biology. They contain an RNA genome and reverse transcriptase enzyme, which allows them to insert their DNA into the host cell genome. Their life cycle involves reverse transcribing their RNA into DNA within the cell. This proviral DNA may then remain latent or produce new viral particles. Retroviral vectors can be engineered to express genes of interest by removing viral genes and adding the gene of interest, allowing them to integrate and persist long-term in infected cells. These vectors have been used to label and study tumor cells, brain development, and the effects of gene expression.
Disclaimer -
The Content belongs to WHO (World Health Organisation). Sharing here is just to spread awareness about Covid-19.
https://www.who.int/docs/default-source/coronaviruse/risk-comms-updates/update37-vaccine-development.pdf?sfvrsn=2581e994_6
The document discusses malaria, which infects hundreds of millions annually and kills over 1 million people per year, mostly in Africa. It outlines the challenges in developing an effective malaria vaccine, including the parasite's ability to evade the immune system and lack of animal models for testing. Several past and current vaccine candidates are mentioned, including SPf66 (the first field trial vaccine), RTS,S (the most advanced candidate to date), and PfSPZ Vaccine (a whole parasite vaccine showing promise in recent trials). Overall, the document reviews the state of malaria vaccine research and the hurdles remaining in developing a highly effective vaccine.
Cancer vaccines aim to stimulate the immune system to recognize and destroy cancer cells. There are several types of cancer vaccines including preventive vaccines, therapeutic vaccines, and personalized neoantigen vaccines. Preventive vaccines target viruses that can cause cancer, while therapeutic vaccines use tumor-associated antigens or cells to treat existing cancers. Future goals include developing vaccines that induce strong and broad T cell responses against cancers and combining vaccines with other immunotherapies to overcome tumor evasion mechanisms. Challenges remain in identifying optimal antigens and vectors to achieve effective anti-tumor responses. Continued research seeks to realize the potential of cancer vaccines for improving patient outcomes and quality of life.
A COVID 19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS CoV 2), the virus causing coronavirus disease 2019 (COVID 19). types of active and inactivated vaccine
Manufacturing the COVID-19 Pandemic Vaccine - Group 2KuchealArivalagan
The document discusses the manufacturing process for COVID-19 vaccines. It describes the traditional vaccine development process which uses weakened pathogens versus the novel mRNA vaccine process used for COVID-19 vaccines which uses genetic code to produce antigens. The manufacturing process for vaccines involves fermentation, purification, formulation, filling and packaging. Challenges in developing COVID-19 vaccines include limited worldwide distribution due to cold chain requirements, lack of long term safety and efficacy data for novel mRNA vaccines, and ensuring proper vaccine administration to stimulate immunity.
Overview of vaccine and vaccination, types of vaccines with examples, vaccine production technique, adverse effects of vaccination, precautions
Email: jeevan@smail.nchu.edu.tw
This document provides an overview of DNA vaccines. It begins with introducing traditional vaccines and how DNA vaccines work. DNA vaccines use genetically engineered DNA that is injected into cells to produce an immunological response. The document then covers the history, development, delivery methods, mechanisms of action, advantages, disadvantages, and current/future applications of DNA vaccines. It summarizes that DNA vaccination is a promising new approach being tested for diseases like Alzheimer's, West Nile virus, and dental caries.
Over 60 million people have been infected with HIV since 1981, and 39.5 million people are currently living with HIV. There are still around 4.3 million new infections each year, and over 28 million people have died of AIDS-related illnesses since the start of the pandemic. Developing an effective HIV vaccine has proven extremely challenging due to the virus's ability to mutate and evade the immune system. While several vaccine candidates have reached clinical trials, none have yet provided reliable, long-term sterilizing immunity. Continued research efforts aim to develop a vaccine that can eliminate HIV infections and end the pandemic.
mRNA rather than DNA may become the nucleotide framework for new classes of drugs and vaccines. Exciting preclinical results in prophylaxis and initial clinical data in oncology suggest that mRNA technology could be translated into improvements in lung cancer and other diseases.
Vaccines are valuable and specialized products, of great diversity have already achieved great success in controlling many diseases of economics importance in farm and companion animals, but present they do not cover all infections, access to modern techniques are used for designing to new vaccine ,not only prolongation of immunity, but also to better practical aspects, such as product stability and less dependence on cold-storage.
Vaccine discovery
DNA vaccine, mechanism
methods of delivery
Main concerns: do DNA vaccines cause insertional mutation and elicit anti-DNA antibodies in the body?
completed and ongoing trials.
new strategies: Prime Boost vaccines
Future prospects
This document provides information about COVID-19 vaccines, including their development process and types. It discusses the phases of clinical drug trials, with Phase 1 trials testing safety in a small group and Phase 3 trials comparing the new vaccine to the standard treatment in thousands of participants. The document also outlines regulatory bodies involved in vaccine development and describes two main types - mRNA vaccines, which introduce mRNA coding for the antigen, and viral vector vaccines, which use another virus to produce the spike protein antigen.
This document summarizes different strategies for developing an HIV vaccine, outlining the challenges and current state of different vaccine types. It discusses how vaccines could potentially prevent or treat HIV infection, and highlights the obstacles like HIV's ability to mutate and target immune cells. Different vaccine types currently in clinical trials are described, including peptides, DNA, live vectors, and recombinant proteins. The largest vaccine trial to date, AIDSVAX, is summarized as stimulating antibodies but not proving effective against HIV.
Therapeutic Cancer Vaccines: A Future of Possibilities Haunted By A History o...Michael Sheckler
These slides provide an overview of 100 therapeutic cancer vaccines in development, a look at some of the failures, what's been and is being done to address the clinical development of these vaccines and a snapshot of some deals, terms and the number of companies seeking commercializations partners.
This document summarizes the history and development of cancer vaccines from early experiments in mice to current human clinical trials. It discusses key concepts like antigen presentation and types of vaccine components. Murine studies showed synergistic effects of combining vaccines with checkpoint inhibitors. Human trials demonstrated the first FDA-approved therapeutic cancer vaccine Provenge for prostate cancer in 2010 and the oncolytic virus therapy T-VEC for melanoma in 2015. Data from the NCI Surgery Branch showed durable responses in some patients treated with personalized peptide vaccines.
mRNA vaccines are a novel vaccine technology that deliver mRNA encoding the antigen protein of a pathogen. This allows the antigen protein to be expressed by the recipient's cells and stimulate an immune response. There are two main types of mRNA vaccines - non-replicating mRNA and self-amplifying mRNA. Delivery strategies include viral carriers like lentivirus or non-viral carriers like liposomes. Administration routes include intramuscular injection, intradermal injection, and intranodal injection. Creative Biolabs offers several mRNA vaccine platforms including non-replicating mRNA vaccines, self-amplifying mRNA vaccines, and dendritic cell mRNA vaccines.
Developing vaccines against infectious and epidemic diseases with the aid of Bioinformatics is now possible, by predicting epitopes on an antigen and finding possible targets for the antibody to bind. A new era of vaccine production is just ahead of us.
Watch out the ppt to know more!!!
mRNA vaccine is a novel vaccine technology, which delivers mRNA that encoding the antigen protein of pathogen to the cell, and expresses the antigen protein, and then stimulates the immune response of the body.
Creative Biolabs has developed non-replicating mRNA vaccine platform, mRNA vaccine platform, mRNA pharmacology optimization platform, and and Self-amplifying mRNA vaccine platform to spport your vaccine researches. If you need more information about mRNA vaccine, please follow us.
This document presents information on vector vaccines. It defines vector vaccines as using live, attenuated microorganisms like viruses or bacteria that have been genetically modified to express antigens from pathogenic organisms. This allows the vector to act as an antigen delivery system, stimulating an immune response against the pathogen. Common viral vectors discussed are vaccinia virus and adenovirus, while bacterial vectors include attenuated Salmonella. The document outlines the process of producing a vaccinia vector vaccine and discusses advantages like strong immunogenicity and ability to induce different types of immune responses. However, it also notes disadvantages such as high production costs and safety concerns in immunocompromised individuals.
Retroviruses can be used as tools in cell biology. They contain an RNA genome and reverse transcriptase enzyme, which allows them to insert their DNA into the host cell genome. Their life cycle involves reverse transcribing their RNA into DNA within the cell. This proviral DNA may then remain latent or produce new viral particles. Retroviral vectors can be engineered to express genes of interest by removing viral genes and adding the gene of interest, allowing them to integrate and persist long-term in infected cells. These vectors have been used to label and study tumor cells, brain development, and the effects of gene expression.
Disclaimer -
The Content belongs to WHO (World Health Organisation). Sharing here is just to spread awareness about Covid-19.
https://www.who.int/docs/default-source/coronaviruse/risk-comms-updates/update37-vaccine-development.pdf?sfvrsn=2581e994_6
The document discusses malaria, which infects hundreds of millions annually and kills over 1 million people per year, mostly in Africa. It outlines the challenges in developing an effective malaria vaccine, including the parasite's ability to evade the immune system and lack of animal models for testing. Several past and current vaccine candidates are mentioned, including SPf66 (the first field trial vaccine), RTS,S (the most advanced candidate to date), and PfSPZ Vaccine (a whole parasite vaccine showing promise in recent trials). Overall, the document reviews the state of malaria vaccine research and the hurdles remaining in developing a highly effective vaccine.
Cancer vaccines aim to stimulate the immune system to recognize and destroy cancer cells. There are several types of cancer vaccines including preventive vaccines, therapeutic vaccines, and personalized neoantigen vaccines. Preventive vaccines target viruses that can cause cancer, while therapeutic vaccines use tumor-associated antigens or cells to treat existing cancers. Future goals include developing vaccines that induce strong and broad T cell responses against cancers and combining vaccines with other immunotherapies to overcome tumor evasion mechanisms. Challenges remain in identifying optimal antigens and vectors to achieve effective anti-tumor responses. Continued research seeks to realize the potential of cancer vaccines for improving patient outcomes and quality of life.
A COVID 19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS CoV 2), the virus causing coronavirus disease 2019 (COVID 19). types of active and inactivated vaccine
Manufacturing the COVID-19 Pandemic Vaccine - Group 2KuchealArivalagan
The document discusses the manufacturing process for COVID-19 vaccines. It describes the traditional vaccine development process which uses weakened pathogens versus the novel mRNA vaccine process used for COVID-19 vaccines which uses genetic code to produce antigens. The manufacturing process for vaccines involves fermentation, purification, formulation, filling and packaging. Challenges in developing COVID-19 vaccines include limited worldwide distribution due to cold chain requirements, lack of long term safety and efficacy data for novel mRNA vaccines, and ensuring proper vaccine administration to stimulate immunity.
HIV causes AIDS by infecting immune cells and weakening the immune system. It is transmitted through bodily fluids and can be prevented by safe sex practices and not sharing needles. The virus attaches to CD4 receptors and integrates its DNA into host cells. This leads to reduced CD4 counts and opportunistic infections defining AIDS. Treatment involves antiretrovirals that target different stages of the viral lifecycle to suppress the virus and ART to control the disease.
Most developments in biotechnology originated for their potential applications in health care.
Contributions of biotechnology are more frequent, more notable and more rewarding in health sector.
This document discusses the development and challenges of HIV vaccines. Over 250 clinical trials have been conducted since the 1980s but an effective vaccine remains elusive due to biological challenges like HIV's ability to mutate. Newer vaccine approaches like mRNA vaccines show promise, with Moderna announcing positive results from a Phase 1 trial of their mRNA HIV vaccine. However, developing a vaccine that provides broad, long-lasting protection against diverse HIV strains and subtypes continues to be hampered by regulatory hurdles and a lack of funding that matches the burden of HIV in developing countries.
This presentation talks about vaccines, currently being used in medicinal processes and therapeutics and their types. It elaborates the importance of the different types of vaccines along with their examples and their mechanism of action. The mode of production of all the types of vaccines is also discussed in the presentation including recent developments made for the production of mRNA vaccine against SARS-CoV-2
This document provides an overview of vaccines including:
- A brief history of vaccines from Edward Jenner's smallpox vaccine to Louis Pasteur's rabies vaccine.
- Descriptions of different types of vaccines including whole organism, subunit, DNA, recombinant vector, and edible vaccines.
- Discussions of immunization programs, challenges in developing an HIV vaccine, the debated link between the MMR vaccine and autism, and the goal of developing more effective and accessible vaccines worldwide.
THE BASIC INFORMATION ABOUT WHAT IS HIV AND HOW IT DESTRUCT THE IMMUNE SYSTEM. THEN LEADS TO AIDS. PRESENTATION ALSO EXPLAINS THE DIAGNOSIS OF HIV, ITS TREATMENT
WHY WE DONT HAVE VACCINE FOR HIV AND WHAT ARE THE PRESENT SCENARIO OF VACCINE DEVELOPMENT..
I HOPE IT WILL EXPLAIN WELL ABOUT HIV INFECTION AND AIDS, MAY PROVE USEFUL FOR YOU GUYS.....
1. The document discusses various questions and answers regarding the Corona virus vaccine. It provides information on the different types of vaccines including whole virus, protein subunit, nucleic acid and viral vector vaccines.
2. Details are given about Indian vaccines like Covaxin and Covishield, developed by Bharat Biotech and Serum Institute of India respectively.
3. Practical issues regarding registration and administration of the vaccine through the CoWIN portal are outlined in steps. Precautions to be taken by cancer patients in taking the vaccine are also explained.
In this section of the coronavirus pandemic series, we discuss the need for an effective COVID-19 vaccine to return to full normalcy. The slides would give a brief overview on how our immune systems work, and how a vaccine would train our immune system to recognize and fight the infection. Current vaccine platform technologies will be compared, and upcoming candidates will be highlighted for newer-generation vaccines. We'll also discuss in-depth on factors involving vaccine manufacturing, hesitancy & acceptance, and contingencies. The market capitalization of pharma companies involved in the development of the coronavirus vaccine will also be compared.
vaccine train user immune system to create antibodies, just as it when it is exposed to a disease. However, because vaccine contain only killed or weakened forms of germs like viruses or bacteria, they do not cause the disease or put you at the risk of complications.
vaccine is a biological preparation that improve immunity to a particular disease.
A vaccine typically contain an agent that resembles a disease causing microorganisms and is often made from weakened or killed forms of the microbes.
This document discusses new generation vaccines and the role of bioinformatics in their development. It defines vaccines and describes problems with conventional vaccines. New generation vaccines include recombinant, DNA, and peptide-based vaccines. Recombinant vaccines use proteins from pathogens produced using genetic engineering. DNA vaccines use only pathogen DNA. Peptide vaccines are built from defined peptide antigens. Bioinformatics plays a key role through genomic analysis, epitope prediction, reverse vaccinology, vaccine design, immunoinformatics, adjuvant prediction, and vaccine surveillance. It integrates various omics data to gain insights into host-pathogen interactions and immune responses to aid vaccine development.
1) The document discusses new generation vaccines, including DNA vaccines, recombinant vaccines, and peptide-based vaccines.
2) It explains how bioinformatics plays a key role in various aspects of developing these new generation vaccines, such as genomic data analysis, epitope prediction, reverse vaccinology, vaccine antigen design, and immunoinformatics.
3) New generation vaccines aim to address limitations of conventional vaccines and leverage cutting-edge technologies enabled by bioinformatics.
This document provides an overview of HIV vaccines, including definitions, estimates of herd immunity thresholds for different diseases, types of vaccines, strategies for preventive and therapeutic HIV vaccines, and summaries of clinical trials. It discusses DNA vaccines, viral vector vaccines, dendritic cell vaccines, therapeutic vaccine candidates, and the Canadian HIV Vaccines Initiative.
The document discusses the history and development of vaccines. It covers key topics like how vaccines work, different types of vaccines including live attenuated and inactivated vaccines, challenges with certain viruses, and new methods being developed like recombinant DNA vaccines, viral vectors, and synthetic peptides. Major successes are highlighted for smallpox and polio vaccines.
Vaccines have been successful in eradicating smallpox and nearly eradicating polio by activating the immune system against viral antigens. Live attenuated vaccines provide both humoral and mucosal immunity but carry risks of reversion, while inactivated vaccines are safer but require boosters. New approaches include recombinant DNA vaccines, which allow production of viral proteins to stimulate both antibody and cytotoxic T-cell responses. Developing an HIV vaccine faces challenges due to the virus's ability to evade the immune system through hiding in cells and polymorphism.
A review on approaches and current progress in the development of HI...ManojKumbhare2
This document provides an overview of HIV vaccine development. It discusses the challenges of developing an HIV vaccine, including the high mutation rate of the virus and lack of appropriate animal models. The document outlines the main approaches to HIV vaccine development, including generating neutralizing antibodies, activating CD8+ T cells through viral vectors, and using prime-boost approaches. It also describes the structure and life cycle of HIV, the disease burden, and immune responses important for a vaccine, such as broadly neutralizing antibodies and cellular immunity. The conclusion states that developing an HIV vaccine remains a significant scientific challenge.
ADVANCES IN USING THE T-MAX PRECISION™ VACCINE PLATFORM AGAINST MAJOR VIRAL ...iQHub
The document summarizes MBF Therapeutics' T-Max Precision DNA vaccine technology and its potential applications. Key points:
- T-Max uses proprietary DNA plasmids encoding antigen sequences to directly stimulate T-cells and induce strong mucosal immunity, addressing limitations of current vaccines.
- Studies show T-Max vaccines for African swine fever and SARS-CoV-2 induce robust CD8+ T-cell responses in pigs and humans.
- The technology could help address significant unmet needs in animal and human vaccines for diseases like influenza, tuberculosis, and others.
This document summarizes key information about HIV/AIDS, including its history, virology, diagnosis, treatment, and prevention. It describes how HIV was first identified in 1981 as the cause of AIDS, belongs to the retrovirus family, and has two types, HIV-1 and HIV-2. Over 30 million people have died of AIDS since 1981, and approximately 2.5 million people are newly infected with HIV each year.
Mercurius is named after the roman god mercurius, the god of trade and science. The planet mercurius is named after the same god. Mercurius is sometimes called hydrargyrum, means ‘watery silver’. Its shine and colour are very similar to silver, but mercury is a fluid at room temperatures. The name quick silver is a translation of hydrargyrum, where the word quick describes its tendency to scatter away in all directions.
The droplets have a tendency to conglomerate to one big mass, but on being shaken they fall apart into countless little droplets again. It is used to ignite explosives, like mercury fulminate, the explosive character is one of its general themes.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Kosmoderma Academy, a leading institution in the field of dermatology and aesthetics, offers comprehensive courses in cosmetology and trichology. Our specialized courses on PRP (Hair), DR+Growth Factor, GFC, and Qr678 are designed to equip practitioners with advanced skills and knowledge to excel in hair restoration and growth treatments.
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
1. Welcome to
JCMI Teleconference
DR. DHRITI GUPTA, DR. VIMALA THAMBI, DR.
HAJARA JOUNDI, DR. KALPANA GIRI, DR.
WARDA HAMEED
CLINICAL EXTERNS, JCMI MEDICAL CENTER, FL
UNDER SUPERVISION OF DR. G. JEAN-CHARLES
JULY 10, 2021
4. Introduction
Over 37.6 million [30.2–45.0 million] people worldwide living with HIV at the end of 2020
About 690 000 [480 000–1 million] people died from HIV-related causes in 2020 and 1.5 million [1.1–
2.1 million] people were newly infected.
Vaccine: An alternative to lifelong Antiretroviral therapy (ART), a functional cure.
Therapeutic
vaccine
But No
effect in HIV
viral load
Classic
vaccine
Low CD8 T-
cell immune
response
5. Why vaccine is important over Antiretroviral therapy?
People living with HIV
No cure No eradication
ART can only suppress HIV replication in infected cells.
It has no impact in latent reservoir.
Reduction in morbidity and mortality.
Treatment is lifelong treatment.
Unable to cure or eradicate the infection.
10. Nucleic acid based vaccines :
Rapid response applications
★ Viral vectors → vector specific immune response (esp on boosting)
★ pDNA → inefficient delivery of pDNA into nucleus of target cells
★ mRNA → do not generate infectious particles or integrate into genome of host cells
11.
12. Why mRNA?
“The mRNA platform makes it easy to develop
vaccines against variants because it just
requires an update to the coding sequences in
the mRNA that code for the variant,” Rajesh
Gandhi, MD, an infectious diseases physician
at Massachusetts General Hospital and chair
of the HIV Medicine Association
Dr. Khalid...?
13. Advantages of mRNA vaccine :
★ Synthetic production
★ Rapid and scalable production
★ Non-infectious, non-integrating,
naturally degraded
★ Stimulate Innate immune response
★ Enhanced Broad T cell and B cell
immune responses
15. Conventional mRNA vaccine :
ADVANTAGES
★ Shorter RNA length
★ Direct Ag expression from mRNA
★ No risk of anti vector immunity
★ Nucleoside based modification
DISADVANTAGES
★ Shorter duration of expression
★ Higher effective doses needed
16. Self amplifying mRNA vaccine :
ADVANTAGES
★ Enhanced and prolonged Ag expression
★ Lower effective doses
★ Vaccine self amplification→
potential apoptosis of vaccine carrying
cells →
enhanced Cross presentation
DISADVANTAGES
★ Longer RNA length → needs
production of high quality mRNA
★ Self amplification→ elevated
inflammation
★ Interaction b/w nSP and host cells
needs to be studied.
20. Pre-requisites for a HIV antibody
•Multiple envelop epitopes
Broad coverage antibody
•Blocks viral entry
Broadly Neutralizing antibody (bnAb)
High titers in the plasma
Long-lasting
CD8+ T cell inducing immunogen
23. Ongoing mRNA vaccine in HIV
Scientists have been working toward an HIV cure for
decades, although a vaccine has so far proven elusive.
Moderna has created an HIV vaccine, working with the
International AIDS Vaccine Initiative (IAVI) and Scripps
Research, that uses mRNA technology in an effort to
generate broadly neutralizing HIV-1 antibodies, or bNAbs,
that act against the virus.
Results from a phase 1 trial show that the desired
response occurred in 97% of participants who received the
vaccine.
27. Sustainability of cold chain
Different vaccines require different
temperatures.
Moderna’s vaccine must be stored at -20
degrees Celsius
Pfizer’s shot that temperature drops to -70 C
29. Myths about mRNA vaccine...
HIV vaccines can give people HIV.
An HIV vaccine already exists.
Joining an HIV vaccine study is like being
a guinea pig.
A person must be HIV-positive (infected)
to be in an HIV vaccine study.
mRNA changes genetic makeup.
30. References:
1. HIV vaccine development - Wikipedia. (2021). Retrieved 10 July 2021, from https://en.wikipedia.org/wiki/HIV_vaccine_development
2. https://www.cell.com/molecular-therapy-family/molecular-therapy/fulltext/S1525-0016(19)30041-3
3. https://www.aidsmap.com/news/mar-2020/hiv-vaccine-generates-broadly-neutralising-antibodies-passes-first-safety-and-proof
4. https://www.genengnews.com/news/mrna-tracking-with-fluorescent-cytosine-preserves-natural-behavior
5. Maruggi G, Zhang C, Li J, Ulmer JB, Yu D. mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases.
Mol Ther. 2019;27(4):757-772. doi:10.1016/j.ymthe.2019.01.020
6. Nurunnabi, Tauhidur & Roy, Bipradas & Sobhani, Mahbub. (2012). Chronic Psychological Stress and AIDS: Biomolecular Mechanisms.
7. Caskey, M., Klein, F., & Nussenzweig, M. (2016). Broadly Neutralizing Antibodies for HIV-1 Prevention or Immunotherapy. New England
Journal Of Medicine, 375(21), 2019-2021. doi: 10.1056/nejmp1613362
8. Mu Z, Haynes BF, Cain DW. HIV mRNA Vaccines-Progress and Future Paths. Vaccines (Basel). 2021;9(2):134. Published 2021 Feb 7.
doi:10.3390/vaccines9020134
9. Esteban I, Pastor-Quiñones C, Usero L, Plana M, García F, Leal L. In the Era of mRNA Vaccines, Is There Any Hope for HIV Functional Cure?
Viruses. 2021 Mar 18;13(3):501. doi: 10.3390/v13030501. PMID: 33803790; PMCID: PMC8003302
10. https://www.who.int/news-room/fact-sheets/detail/hiv-aids
11. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjJ7qroq9jxAhVCzjgGHSHvAWkQFjABegQIHhAD&u
rl=https%3A%2F%2Fwww.contagionlive.com%2Fview%2Fmoderna-unveils-results-of-new-mrna-vaccine-candidate-
trials&usg=AOvVaw0qL6RbSbgR9xuC6YzJ6Nvs
12. https://www.promegaconnections.com/mrna-vaccines-for-covid-19-the-promise-and-
pitfalls/?utm_source=youtube&utm_medium=social&utm_campaign=mRNA%20vaccine%20video&utm_term=description
31. Thank You.
“COVID-19 showed us what we can do if we want to move a vaccine forward quickly”
Andrew Pekosz, PhD, Virologists
Please add your names girls.Let’s not reveal the topic in the start.
Do you think mRNA vaccines are new?
For decades, researchers have been studying mRNA vaccines for viruses like Zika, rabies, and even the flu.1
But the technology hasn't been used on humans until 2020 for COVID-19.